Brain Injury RESEARCH
Medication for Irritability and Aggression after Traumatic Brain Injury
The purpose of this four-month study is to evaluate the effectiveness of a medication called buspirone in reducing irritability and/or aggression after traumatic brain injury (TBI). Subjects will be given either buspirone or placebo during the first three months of the study. On the fourth month, all subjects will be given a 30-day supply of the active medication. Subject and Caregiver participation is required for this study.
This study is funded by National Institute on Disability, Independent Living, and Rehabilitation Research.
Flora McConnell Hammond, MD View Biography